MELISSA HYNEK: Open Payments
NPI 1366770489 · COUNCIL BLUFFS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 18 payments from 9 companies in 2025. Trend: 2023 $217 · 2024 $350 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 7 | $81 |
| Sumitomo Pharma America, Inc. | 3 | $73 |
| Astellas Pharma US Inc | 2 | $60 |
| CooperSurgical, Inc. | 1 | $24 |
| Biogen, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $19 |
| Heron Therapeutics, Inc. | 1 | $17 |
| Exeltis, USA Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: MYFEMBREE, Veozah, Paragard T 380A, ZURZUVAE, ZEPBOUND, ZYNRELEF, SLYND, Cologuard Collection Kit.
Industry payments across IA — which companies pay providers there.
